Page last updated: 2024-08-24

ferric citrate and Hypoxia

ferric citrate has been researched along with Hypoxia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kwon, TK; Lee, TJ; Park, JW; Woo, KJ	1

Other Studies

1 other study(ies) available for ferric citrate and Hypoxia

Article	Year
Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway. Biochemical and biophysical research communications, 2006, Apr-28, Volume: 343, Issue:1 Topics: Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Deferoxamine; Ferric Compounds; Flavonoids; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Mitogen-Activated Protein Kinases; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2006

Article

Year

Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway.

Biochemical and biophysical research communications, 2006, Apr-28, Volume: 343, Issue:1

Topics: Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Deferoxamine; Ferric Compounds; Flavonoids; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Mitogen-Activated Protein Kinases; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2006